Cargando…

Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target

Over the years, substantial evidence has definitively confirmed the existence of cancer stem-like cells within tumors such as Glioblastoma (GBM). The importance of Glioblastoma stem-like cells (GSCs) in tumor progression and relapse clearly highlights that cancer eradication requires killing of GSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garnier, Delphine, Renoult, Ophélie, Alves-Guerra, Marie-Clotilde, Paris, François, Pecqueur, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415584/ https://www.ncbi.nlm.nih.gov/pubmed/30895167 http://dx.doi.org/10.3389/fonc.2019.00118

Ejemplares similares

Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma
por: Alzial, Gabriel, et al.
Publicado: (2021)

Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model
por: Oizel, Kristell, et al.
Publicado: (2020)

Exploiting radiation immunostimulatory effects to improve glioblastoma outcome
por: Awada, Hala, et al.
Publicado: (2022)

UCP2 induces metabolic reprogramming to inhibit proliferation of cancer cells
por: Esteves, Pauline, et al.
Publicado: (2014)

UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling
por: Sancerni, Tiphaine, et al.
Publicado: (2022)

The antitumor activity of human Vγ9Vδ2 T cells is impaired by TGF-β through significant phenotype, transcriptomic and metabolic changes
por: Rafia, Chirine, et al.
Publicado: (2023)

Strategies of the War on Cancer: To Kill or to Neutralize?
por: Lichtenstein, Anatoly V.
Publicado: (2019)

PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells
por: Seifert, Carolin, et al.
Publicado: (2021)

Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside
por: Fleurence, Julien, et al.
Publicado: (2016)

Ceramide Composition in Exosomes for Characterization of Glioblastoma Stem-Like Cell Phenotypes
por: Melero-Fernandez de Mera, Raquel M., et al.
Publicado: (2022)

Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies
por: Harland, Abigail, et al.
Publicado: (2021)

Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges
por: Bastiancich, Chiara, et al.
Publicado: (2021)

Prolonged Response Induced by Single Agent Vemurafenib in a BRAF V600E Spinal Ganglioglioma: A Case Report and Review of the Literature
por: Garnier, Louis, et al.
Publicado: (2019)

Targeting Aggressive Cancer Stem Cells in Glioblastoma
por: Seymour, Tracy, et al.
Publicado: (2015)

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2021)

Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
por: Garros-Regulez, Laura, et al.
Publicado: (2016)

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
por: Chaddad, Ahmad, et al.
Publicado: (2019)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
por: Zhang, Xu, et al.
Publicado: (2022)

Analysis of Uncoupling Protein 2-Deficient Mice upon Anaesthesia and Sedation Revealed a Role for UCP2 in Locomotion
por: Alves-Guerra, Marie-Clotilde, et al.
Publicado: (2012)

Osteoarthritic chondrocytes undergo a glycolysis-related metabolic switch upon exposure to IL-1b or TNF
por: Defois, Anais, et al.
Publicado: (2023)

Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Glioblastoma
por: Iranmanesh, Yasaman, et al.
Publicado: (2021)

Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma
por: Zhao, Nan, et al.
Publicado: (2021)

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
por: Signore, M, et al.
Publicado: (2014)

The low affinity A2B adenosine receptor enhances migratory and invasive capacity in vitro and angiogenesis in vivo of glioblastoma stem-like cells
por: Erices, José I., et al.
Publicado: (2022)

Novel mTORC1 Inhibitors Kill Glioblastoma Stem Cells
por: Sandoval, Jose A., et al.
Publicado: (2020)

Neural Stem Cells of the Subventricular Zone as the Origin of Human Glioblastoma Stem Cells. Therapeutic Implications
por: Matarredona, Esperanza R., et al.
Publicado: (2019)

Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization
por: Silver, Aryeh, et al.
Publicado: (2022)

Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence
por: Ellis, Hayley P., et al.
Publicado: (2015)

Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives
por: Raucher, Drazen, et al.
Publicado: (2018)

Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

P4HA1 Regulates CD31 via COL6A1 in the Transition of Glioblastoma Stem-Like Cells to Tumor Endothelioid Cells
por: Han, Xiangming, et al.
Publicado: (2022)

Editorial: Neural Stem Cells of the Subventricular Zone: From Neurogenesis to Glioblastoma Origin
por: Matarredona, Esperanza R., et al.
Publicado: (2021)

Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities
por: Johnson, Amanda L., et al.
Publicado: (2022)

Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal
por: Marcucci, Fabrizio, et al.
Publicado: (2016)

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells
por: Dent, Paul, et al.
Publicado: (2020)

Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells
por: Roberts, Jane L., et al.
Publicado: (2021)

Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells
por: Rackov, Gorjana, et al.
Publicado: (2020)

Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy
por: Tang, Xuejia, et al.
Publicado: (2021)

Glioblastoma Distance From the Subventricular Neural Stem Cell Niche Does Not Correlate With Survival
por: Mistry, Akshitkumar M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_295i2qdk0fat9tv1gri5iqk8h4